Mohit Kukreja, V G Telang and Chetan Anchan. Atypical Presentation of Primary Non-metastatic Ewings Sarcoma of the Lumbosacral Spine-“Cauda Equina Syndrome” Clinically and a “Tuberculosis mimicking challenge” on MRI-A Case Report.
. 2017; 5(8):221-225. doi: 10.12691/AJMCR-5-8-5
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | J. A. Ellis, R. J. Rothrock, G. Moise et al., “Primitive neuroectodermal tumors of the spine: a comprehensive review with illustrative clinical cases,” Neurosurgical Focus, vol. 30, no. 1, pp. 1-13, 2011. |
|
[2] | L. Venkateswaran, C. Rodriguez-Galindo, T. E. Merchant, C. A. Poquette, B. N. Rao, and A. S. Pappo, “Primary Ewing tumor of the vertebrae: clinical characteristics, prognostic factors, and outcome,” Medical and Pediatric Oncology, vol. 37, no. 1, pp. 30-35, 2001. |
|
[3] | C. Rodriguez-Galindo, S. L. Spunt, and A. S. Pappo, “Treatment of ewing sarcoma family of tumors: current status and outlook for the future,” Medical and Pediatric Oncology, vol. 40, no. 5, pp. 276-287, 2003. |
|
[4] | K. Fizazi, N. Dohollou, J. Y. Blay et al., “Ewing’s family of tumors in adults: multivariate analysis of survival and longterm results of multimodality therapy in 182 patients,” Journal of Clinical Oncology, vol. 16, no. 12, pp. 3736-3743, 1998. |
|
[5] | S. J. Cotterill, S. Ahrens, M. Paulussen et al., “Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma StudyGroup,” Journal of Clinical Oncology, vol. 18, no. 17, pp. 3108-3114, 2000. |
|
[6] | G. Bacci, S. Ferrari, F. Bertoni et al., “Prognostic factors in nonmetastatic Ewing’s sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli,” Journal of Clinical Oncology, vol. 18, no. 1, pp. 4-11, 2000. |
|
[7] | H. Ilaslan, M. Sundaram, K. K. Unni, and M. B. Dekutoski, “Primary Ewing’s sarcoma of the vertebral column,” Skeletal Radiology, vol. 33, no. 9, pp. 506-513, 2004. |
|
[8] | A. A. Gupta, A. Pappo, N. Saunders et al., “Clinical outcome of children and adults with localized ewing sarcoma: impact of chemotherapy dose and timing of local therapy,” Cancer, vol.116, no. 13, pp. 3189-3194, 2010. |
|
[9] | G. Gatta, J. M. Van Der Zwan, P. G. Casali et al., “Rare cancers are not so rare: the rare cancer burden in Europe,” European Journal of Cancer, vol. 47, no. 17, pp. 2493-2511, 2011. |
|
[10] | K.R. Weiss, D.J. Biau, and R. Bhumbra, “Axial skeletal location predicts poor outcome in Ewing,” Sarcoma, vol. 2011, Article ID 395180, 5 pages, 2011. |
|
[11] | H. W. Hense, S. Ahrens, M. Paulussen, M. Lehnert, and H. Jürgens, “Factors associated with tumor volume and primary metastases in Ewing tumors: results from the (EI) CESS studies,” Annals of Oncology, vol. 10, no. 9, pp. 1073-1077, 1999. |
|
[12] | M. J. A. Sharafuddin, F. S. Haddad, P. W. Hitchon, S. F. Haddad, and G. Y. El-Khoury, “Treatment options in primary Ewing’s sarcoma of the spine: report of seven cases and review of the literature,” Neurosurgery, vol. 30, no. 4, pp. 610-619, 1992. |
|
[13] | Dhatt S, Dhillon MS, Tripathy SK, Goyal T, Jagadeesh V. Peripheral primitive neuroectodermal tumor causing cauda equina syndrome with destruction of L5 vertebra. Indian J Orthop, 44, pp. 339-41, 2010. |
|
[14] | Jithendra K S,rachna S ,karak AK ,Thavaraj V, Kabra SK. Primitive Neuroectodermal Tumor presenting as Cauda equine syndrome. Indian J Med and Paediatr Oncol, 28, pp. 34-37, 2007. |
|
[15] | Krishnakumar R, Renjitkumar J. Acute cauda equina syndrome due to primary Ewing's sarcoma of the spine. Neurol India, 59, pp. 931-3, 2011. |
|
[16] | Llauger J, Palmer J, Amores S, Bague S, Camins A. Primary Tumors of Sacrum-Diagnostic Imaging. American Roentgen Ray Society. 174, pp. 417-24, 2000. |
|
[17] | Gagnier, Joel J., et al. “The CARE guidelines: consensus-based clinical case reporting guideline development.” Journal of medical case reports, 7.1, pp. 23, 2013. |
|